Literature DB >> 8340750

Inhibition of c-fes expression by an antisense oligomer causes apoptosis of HL60 cells induced to granulocytic differentiation.

R Manfredini1, A Grande, E Tagliafico, D Barbieri, P Zucchini, G Citro, G Zupi, C Franceschi, U Torelli, S Ferrari.   

Abstract

The c-fes protooncogene is expressed at high levels in the terminal stages of granulocytic differentiation, but so far no definite function has been attributed to the product of this oncogene. To tackle this problem, the c-fes protooncogene expression has been inhibited in HL60 cells, and fresh leukemic promyelocytes of acute promyelocytic leukemia have been induced to differentiate with retinoic acid (RA) and dimethylsulfoxide (DMSO). Inhibition was obtained by incubating the cells with a specific c-fes antisense oligodeoxynucleotide. It was observed that the cells, rather than differentiating, underwent premature cell death showing the morphological and molecular characteristics of apoptosis. This process was inhibited by granulocyte and granulocyte/macrophage colony-stimulating factor, but not by interleukin 3 (IL-3), IL-6, or stem cell factor. Our present results demonstrate that the loss of cell viability that occurs during the in vitro differentiation of myeloid cells, after the complete inhibition of the c-fes gene product and treatment with RA-DMSO, is due to activation of programmed cell death. It is concluded that a possible role of the c-fes gene product is to exert an antiapoptotic effect during granulocytic differentiation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8340750      PMCID: PMC2191130          DOI: 10.1084/jem.178.2.381

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  Noncoordinated expression of S6, S11, and S14 ribosomal protein genes in leukemic blast cells.

Authors:  S Ferrari; R Manfredini; E Tagliafico; E Rossi; A Donelli; G Torelli; U Torelli
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

2.  Characterization of human and mouse c-fes cDNA clones and identification of the 5' end of the gene.

Authors:  M Alcalay; F Antolini; W J Van de Ven; L Lanfrancone; F Grignani; P G Pelicci
Journal:  Oncogene       Date:  1990-03       Impact factor: 9.867

3.  HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis.

Authors:  S J Martin; J G Bradley; T G Cotter
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

4.  Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.

Authors:  J C Reed; C Stein; C Subasinghe; S Haldar; C M Croce; S Yum; J Cohen
Journal:  Cancer Res       Date:  1990-10-15       Impact factor: 12.701

5.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.

Authors:  D Hockenbery; G Nuñez; C Milliman; R D Schreiber; S J Korsmeyer
Journal:  Nature       Date:  1990-11-22       Impact factor: 49.962

6.  The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus.

Authors:  H de Thé; C Chomienne; M Lanotte; L Degos; A Dejean
Journal:  Nature       Date:  1990-10-11       Impact factor: 49.962

7.  Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis.

Authors:  S J Martin; S V Lennon; A M Bonham; T G Cotter
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

8.  Myeloid expression of the human c-fps/fes proto-oncogene in transgenic mice.

Authors:  P Greer; V Maltby; J Rossant; A Bernstein; T Pawson
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

Review 9.  Antisense strategies in cell and developmental biology.

Authors:  A Colman
Journal:  J Cell Sci       Date:  1990-11       Impact factor: 5.285

10.  Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus.

Authors:  M Alcalay; D Zangrilli; P P Pandolfi; L Longo; A Mencarelli; A Giacomucci; M Rocchi; A Biondi; A Rambaldi; F Lo Coco
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

View more
  8 in total

1.  Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1.

Authors:  Jynho Kim; Ricardo A Feldman
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

2.  Potent and selective gene inhibition using antisense oligodeoxynucleotides.

Authors:  W M Flanagan; R W Wagner
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

3.  The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor.

Authors:  A Heydemann; G Juang; K Hennessy; M S Parmacek; M C Simon
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  The cytoplasmic tyrosine kinase FER is associated with the catenin-like substrate pp120 and is activated by growth factors.

Authors:  L Kim; T W Wong
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

5.  A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells.

Authors:  H Y Cheng; A P Schiavone; T E Smithgall
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  Phospholipase D2 (PLD2) shortens the time required for myeloid leukemic cell differentiation: mechanism of action.

Authors:  Mauricio Di Fulvio; Kathleen Frondorf; Karen M Henkels; William C Grunwald; David Cool; Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2011-11-17       Impact factor: 5.157

7.  Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells.

Authors:  X Jiang; J Li; M Paskind; P M Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils.

Authors:  S Yousefi; D C Hoessli; K Blaser; G B Mills; H U Simon
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.